Search results

  1. Wyva

    Redox imbalance links COVID-19 and myalgic encephalomyelitis/chronic fatigue syndrome, 2021, Paul, Komaroff et al

    Abstract Although most patients recover from acute COVID-19, some experience postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (PASC). One subgroup of PASC is a syndrome called “long COVID-19,” reminiscent of myalgic encephalomyelitis/chronic fatigue syndrome...
  2. Wyva

    COVID-19 is getting on our nerves: sympathetic neural activity and hemodynamics in young adults recovering from SARS-CoV-2, 2021, Stute et al

    Abstract Key points The impact of SARS-CoV-2 infection on autonomic and cardiovascular function in otherwise healthy individuals is unknown. We show for the first time that young adults recovering from SARS-CoV-2 have elevated resting sympathetic activity, but similar heart rate and blood...
  3. Wyva

    News about Long Covid including its relationship to ME/CFS 2020 to 2021

    How Long COVID Is Helping Young Women With Chronic Fatigue Syndrome Quite a long article about the parallels between the two diseases, mostly quoting David Strain and Sonya Chowdhury. The Royal Free Hospital outbreak is also mentioned. However, I didn't really like that Strain talked about...
  4. Wyva

    Health, Wellbeing and Prognosis of Australian Adolescents with(ME/CFS): A Case-Controlled Follow-up Study, 2021, Josev et al

    They used the Canadian Consensus Criteria. This is what they said at the end: "Given the observed persistence of ME/CFS symptoms, poorer health and reduced psychological well-being at follow-up compared with healthy controls (i.e., fatigue, pain, and health-related quality of life problems)...
  5. Wyva

    USA: Congress Approves Over a Billion Dollars to Study Covid-19

    I remembered this from an article, although I'm not sure what they based it on: "Grant awards for the long COVID initiative are expected to be announced in the coming weeks." The article was written in May...
  6. Wyva

    USA: INSPIRE Innovative Support for Patients with Covid-19 Registry (ME/CFS outcome measure)

    It looks like the incidence of ME/CFS is a secondary outcome now (instead of primary): https://ichgcp.net/clinical-trials-registry/NCT04610515 Primary Outcome Measure Time Frame Assess for medium and long-term sequalae of SARS-CoV-2 infection 18 months post enrollment Secondary Outcome Measure...
Back
Top Bottom